Published in Schizophr Res on August 16, 2011
Functional milestones and clinician ratings of everyday functioning in people with schizophrenia: overlap between milestones and specificity of ratings. J Psychiatr Res (2012) 0.93
When functional capacity and real-world functioning converge: the role of self-efficacy. Schizophr Bull (2012) 0.92
Self-assessment of functional ability in schizophrenia: milestone achievement and its relationship to accuracy of self-evaluation. Psychiatry Res (2013) 0.88
Cortical substrates and functional correlates of auditory deviance processing deficits in schizophrenia. Neuroimage Clin (2014) 0.85
The utility of P300 as a schizophrenia endophenotype and predictive biomarker: clinical and socio-demographic modulators in COGS-2. Schizophr Res (2014) 0.83
Initial validation of a computerized version of the UCSD Performance-Based Skills Assessment (C-UPSA) for assessing functioning in schizophrenia. Schizophr Res (2013) 0.82
Antipsychotic treatments; focus on lurasidone. Front Pharmacol (2013) 0.82
Psychometric evaluation of the Work Readiness Questionnaire in schizophrenia. CNS Spectr (2014) 0.80
UPSA-M: Feasibility and initial validity of a mobile application of the UCSD Performance-Based Skills Assessment. Schizophr Res (2015) 0.80
Gesture Performance in Schizophrenia Predicts Functional Outcome After 6 Months. Schizophr Bull (2016) 0.79
Self-efficacy and functional status in schizophrenia: relationship to insight, cognition and negative symptoms. Schizophr Res (2013) 0.78
Employment and the associated impact on quality of life in people diagnosed with schizophrenia. Neuropsychiatr Dis Treat (2015) 0.77
Report on ISCTM Consensus Meeting on Clinical Assessment of Response to Treatment of Cognitive Impairment in Schizophrenia. Schizophr Bull (2015) 0.76
Rorschach measures of cognition relate to everyday and social functioning in schizophrenia. Psychol Assess (2012) 0.76
Conducting Psychopathology Prevention Research in the RDoC Era. Clin Psychol (New York) (2016) 0.76
Functional Capacity Assessed by the Map Task in Individuals at Clinical High-Risk for Psychosis. Schizophr Bull (2016) 0.75
Towards a framework for treatment effectiveness in schizophrenia. Neuropsychiatr Dis Treat (2014) 0.75
Technology to assess and support self-management in serious mental illness. Dialogues Clin Neurosci (2016) 0.75
Assessment of Lifespan Functioning Attainment (ALFA) scale: A quantitative interview for self-reported current and functional decline in schizophrenia. J Psychiatr Res (2015) 0.75
Exploratory analysis of normative performance on the UCSD Performance-Based Skills Assessment-Brief. Psychiatry Res (2017) 0.75
The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull (1987) 51.07
Index for rating diagnostic tests. Cancer (1950) 27.09
What are the functional consequences of neurocognitive deficits in schizophrenia? Am J Psychiatry (1996) 11.03
Systematic reviews in health care: Systematic reviews of evaluations of diagnostic and screening tests. BMJ (2001) 9.63
Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the "right stuff"? Schizophr Bull (2000) 9.62
Determinants of real-world functional performance in schizophrenia subjects: correlations with cognition, functional capacity, and symptoms. Am J Psychiatry (2006) 4.77
Antipsychotic dose equivalents and dose-years: a standardized method for comparing exposure to different drugs. Biol Psychiatry (2009) 4.44
Predicting schizophrenia patients' real-world behavior with specific neuropsychological and functional capacity measures. Biol Psychiatry (2007) 3.42
Bipolar I disorder and schizophrenia: a 440-single-nucleotide polymorphism screen of 64 candidate genes among Ashkenazi Jewish case-parent trios. Am J Hum Genet (2005) 3.03
Development of a brief scale of everyday functioning in persons with serious mental illness. Schizophr Bull (2007) 2.47
Barriers to employment for people with schizophrenia. Am J Psychiatry (2006) 2.42
Generalized cognitive impairments, ability to perform everyday tasks, and level of independence in community living situations of older patients with psychosis. Am J Psychiatry (2002) 2.39
Understanding receiver operating characteristic (ROC) curves. CJEM (2006) 2.38
Performance-based measures of functional skills: usefulness in clinical treatment studies. Schizophr Bull (2007) 2.00
Evaluation of functionally meaningful measures for clinical trials of cognition enhancement in schizophrenia. Am J Psychiatry (2011) 1.86
Cognitive functioning, symptoms, and work in supported employment: a review and heuristic model. Schizophr Res (2004) 1.71
Usefulness of the UCSD performance-based skills assessment (UPSA) for predicting residential independence in patients with chronic schizophrenia. J Psychiatr Res (2007) 1.67
Performance-based measurement of functional disability in schizophrenia: a cross-national study in the United States and Sweden. Am J Psychiatry (2009) 1.65
Signatures of founder effects, admixture, and selection in the Ashkenazi Jewish population. Proc Natl Acad Sci U S A (2010) 1.64
Validating the measurement of real-world functional outcomes: phase I results of the VALERO study. Am J Psychiatry (2011) 1.47
Genomewide linkage scan for schizophrenia susceptibility loci among Ashkenazi Jewish families shows evidence of linkage on chromosome 10q22. Am J Hum Genet (2003) 1.40
A review of instruments for measuring functional recovery in those diagnosed with psychosis. Schizophr Bull (2008) 1.33
Genomewide linkage scan for bipolar-disorder susceptibility loci among Ashkenazi Jewish families. Am J Hum Genet (2004) 1.29
Fine mapping on chromosome 10q22-q23 implicates Neuregulin 3 in schizophrenia. Am J Hum Genet (2009) 1.27
Measures and predictors of community-based employment and earnings of persons with schizophrenia in a multisite study. Psychiatr Serv (2007) 1.04
Assessment of social skills. Schizophr Bull (1982) 1.02
Performance-based assessment of functional skills in severe mental illness: results of a large-scale study in China. J Psychiatr Res (2011) 1.00
Relationship between functional capacity and community responsibility in patients with schizophrenia: differences between independent and assisted living settings. Community Ment Health J (2008) 0.97
Measurement of functional capacity: a new approach to understanding functional differences and real-world behavioral adaptation in those with mental illness. Annu Rev Clin Psychol (2010) 0.94
Genome-wide association analysis identifies 13 new risk loci for schizophrenia. Nat Genet (2013) 7.44
Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: Schizophrenia. Am J Hum Genet (2003) 6.63
Analysis and application of European genetic substructure using 300 K SNP information. PLoS Genet (2008) 6.42
Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial. Arch Gen Psychiatry (2007) 5.64
Determinants of real-world functional performance in schizophrenia subjects: correlations with cognition, functional capacity, and symptoms. Am J Psychiatry (2006) 4.77
White matter changes in schizophrenia: evidence for myelin-related dysfunction. Arch Gen Psychiatry (2003) 4.25
Correlates of injection drug use among female sex workers in two Mexico-U.S. border cities. Drug Alcohol Depend (2007) 4.04
Trends in production, trafficking, and consumption of methamphetamine and cocaine in Mexico. Subst Use Misuse (2006) 4.01
The classification of inherited epidermolysis bullosa (EB): Report of the Third International Consensus Meeting on Diagnosis and Classification of EB. J Am Acad Dermatol (2008) 3.72
Historical trends in the production and consumption of illicit drugs in Mexico: implications for the prevention of blood borne infections. Drug Alcohol Depend (2005) 3.67
The Brief Assessment of Cognition in Schizophrenia: reliability, sensitivity, and comparison with a standard neurocognitive battery. Schizophr Res (2004) 3.57
Predicting schizophrenia patients' real-world behavior with specific neuropsychological and functional capacity measures. Biol Psychiatry (2007) 3.42
Potential of fibroblast cell therapy for recessive dystrophic epidermolysis bullosa. J Invest Dermatol (2008) 3.34
Combined analysis from eleven linkage studies of bipolar disorder provides strong evidence of susceptibility loci on chromosomes 6q and 8q. Am J Hum Genet (2005) 3.24
Individual, social, and environmental influences associated with HIV infection among injection drug users in Tijuana, Mexico. J Acquir Immune Defic Syndr (2008) 3.14
Motivations associated with methamphetamine use among HIV+ men who have sex with men. J Subst Abuse Treat (2002) 3.13
Estimated numbers of men and women infected with HIV/AIDS in Tijuana, Mexico. J Urban Health (2006) 3.04
Bipolar I disorder and schizophrenia: a 440-single-nucleotide polymorphism screen of 64 candidate genes among Ashkenazi Jewish case-parent trios. Am J Hum Genet (2005) 3.03
The Schizophrenia Cognition Rating Scale: an interview-based assessment and its relationship to cognition, real-world functioning, and functional capacity. Am J Psychiatry (2006) 2.95
Bone marrow transplantation for recessive dystrophic epidermolysis bullosa. N Engl J Med (2010) 2.82
Club drugs as causal risk factors for HIV acquisition among men who have sex with men: a review. Subst Use Misuse (2006) 2.81
Mobile interventions for severe mental illness: design and preliminary data from three approaches. J Nerv Ment Dis (2010) 2.80
Loss of kindlin-1, a human homolog of the Caenorhabditis elegans actin-extracellular-matrix linker protein UNC-112, causes Kindler syndrome. Am J Hum Genet (2003) 2.73
Baseline neurocognitive deficits in the CATIE schizophrenia trial. Neuropsychopharmacology (2006) 2.70
Self-assessment of functional status in schizophrenia. J Psychiatr Res (2006) 2.65
Risperidone and haloperidol in first-episode psychosis: a long-term randomized trial. Am J Psychiatry (2005) 2.62
Assessment of community functioning in people with schizophrenia and other severe mental illnesses: a white paper based on an NIMH-sponsored workshop. Schizophr Bull (2006) 2.53
Differential effects of migration and deportation on HIV infection among male and female injection drug users in Tijuana, Mexico. PLoS One (2008) 2.51
Characteristics of female sex workers with US clients in two Mexico-US border cities. Sex Transm Dis (2008) 2.48
Development of a brief scale of everyday functioning in persons with serious mental illness. Schizophr Bull (2007) 2.47
Characterizing affective instability in borderline personality disorder. Am J Psychiatry (2002) 2.44
Lipoid proteinosis maps to 1q21 and is caused by mutations in the extracellular matrix protein 1 gene (ECM1). Hum Mol Genet (2002) 2.41
The effect of adherence on the association between depressive symptoms and mortality among HIV-infected individuals first initiating HAART. AIDS (2007) 2.39
Generalized cognitive impairments, ability to perform everyday tasks, and level of independence in community living situations of older patients with psychosis. Am J Psychiatry (2002) 2.39
Microdeletions of 3q29 confer high risk for schizophrenia. Am J Hum Genet (2010) 2.38
Prediction of real-world functional disability in chronic mental disorders: a comparison of schizophrenia and bipolar disorder. Am J Psychiatry (2010) 2.35
Social and structural factors associated with HIV infection among female sex workers who inject drugs in the Mexico-US border region. PLoS One (2011) 2.34
The effects of hypertension and body mass index on cognition in schizophrenia. Am J Psychiatry (2010) 2.33
A qualitative exploration of female sex work in Tijuana, Mexico. Arch Sex Behav (2004) 2.31
The emerging HIV epidemic on the Mexico-U.S. border: an international case study characterizing the role of epidemiology in surveillance and response. Ann Epidemiol (2012) 2.28
Neuropsychological impairments in schizophrenia: Integration of performance-based and brain imaging findings. Psychol Bull (2007) 2.25
Negative symptoms and cognitive deficits: what is the nature of their relationship? Schizophr Bull (2005) 2.20
Administration and interpretation of the Trail Making Test. Nat Protoc (2006) 2.18
Efficacy of a behavioral intervention for increasing safer sex behaviors in HIV-positive MSM methamphetamine users: results from the EDGE study. Drug Alcohol Depend (2006) 2.17
Assessing disability in older patients with schizophrenia: results from the WHODAS-II. J Nerv Ment Dis (2004) 2.12
Association between older age and more successful aging: critical role of resilience and depression. Am J Psychiatry (2013) 2.11
Diffusion tensor imaging findings in first-episode and chronic schizophrenia patients. Am J Psychiatry (2008) 2.11
Homelessness and unstable housing associated with an increased risk of HIV and STI transmission among street-involved youth. Health Place (2009) 2.07
Validating a shortened depression scale (10 item CES-D) among HIV-positive people in British Columbia, Canada. PLoS One (2012) 2.02
The molecular basis of lipoid proteinosis: mutations in extracellular matrix protein 1. Exp Dermatol (2007) 1.98
Direct assessment of functional abilities: relevance to persons with schizophrenia. Schizophr Res (2004) 1.97
Recurrent mutations in kindlin-1, a novel keratinocyte focal contact protein, in the autosomal recessive skin fragility and photosensitivity disorder, Kindler syndrome. J Invest Dermatol (2004) 1.95
Mutations in the gene encoding capillary morphogenesis protein 2 cause juvenile hyaline fibromatosis and infantile systemic hyalinosis. Am J Hum Genet (2003) 1.94
A lifestyle intervention for older schizophrenia patients with diabetes mellitus: a randomized controlled trial. Schizophr Res (2006) 1.94
Characteristics of the MATRICS Consensus Cognitive Battery in a 29-site antipsychotic schizophrenia clinical trial. Schizophr Res (2010) 1.91
Measurement and predictors of resilience among community-dwelling older women. J Psychiatr Res (2008) 1.91
Evaluation of functionally meaningful measures for clinical trials of cognition enhancement in schizophrenia. Am J Psychiatry (2011) 1.86
[Estimating the 2006 prevalence of HIV by gender and risk groups in Tijuana, Mexico]. Gac Med Mex (2009) 1.86
Overrepresentation of rare variants in a specific ethnic group may confuse interpretation of association analyses. Hum Mol Genet (2006) 1.84
Sleep in spousal caregivers of people with Alzheimer's disease. Sleep (2005) 1.83
Building blocks of successful aging: a focus group study of older adults' perceived contributors to successful aging. Am J Geriatr Psychiatry (2007) 1.82
Neuropsychological function and dysfunction in schizophrenia and psychotic affective disorders. Schizophr Bull (2008) 1.81
Female methamphetamine users: social characteristics and sexual risk behavior. Women Health (2004) 1.81
An exploration of contextual factors that influence HIV risk in female sex workers in Mexico: The Social Ecological Model applied to HIV risk behaviors. AIDS Care (2009) 1.80
Neuropsychological functioning in bipolar disorder and schizophrenia. Biol Psychiatry (2006) 1.80
A review of performance-based measures of functional living skills. J Psychiatr Res (2005) 1.73
Is schizophrenia a syndrome of accelerated aging? Schizophr Bull (2007) 1.70
Usefulness of the UCSD performance-based skills assessment (UPSA) for predicting residential independence in patients with chronic schizophrenia. J Psychiatr Res (2007) 1.67
Extracellular matrix protein 1 gene (ECM1) mutations in lipoid proteinosis and genotype-phenotype correlation. J Invest Dermatol (2003) 1.67
The context of sexual risk behavior among heterosexual methamphetamine users. Addict Behav (2004) 1.67
Determinants of everyday outcomes in schizophrenia: the influences of cognitive impairment, functional capacity, and symptoms. Schizophr Res (2009) 1.66
The international dystrophic epidermolysis bullosa patient registry: an online database of dystrophic epidermolysis bullosa patients and their COL7A1 mutations. Hum Mutat (2011) 1.65
Performance-based measurement of functional disability in schizophrenia: a cross-national study in the United States and Sweden. Am J Psychiatry (2009) 1.65
Signatures of founder effects, admixture, and selection in the Ashkenazi Jewish population. Proc Natl Acad Sci U S A (2010) 1.64
Cognition in schizophrenia: impairments, determinants, and functional importance. Psychiatr Clin North Am (2005) 1.63
Brain mitochondrial injury in human immunodeficiency virus-seropositive (HIV+) individuals taking nucleoside reverse transcriptase inhibitors. J Neurovirol (2005) 1.62
Exergames for subsyndromal depression in older adults: a pilot study of a novel intervention. Am J Geriatr Psychiatry (2010) 1.59
European population genetic substructure: further definition of ancestry informative markers for distinguishing among diverse European ethnic groups. Mol Med (2009) 1.59
A double blind placebo controlled trial of donepezil adjunctive treatment to risperidone for the cognitive impairment of schizophrenia. Biol Psychiatry (2002) 1.59
No major schizophrenia locus detected on chromosome 1q in a large multicenter sample. Science (2002) 1.57
Cognitive impairment in schizophrenia. Handb Exp Pharmacol (2012) 1.57
Patients with recessive dystrophic epidermolysis bullosa develop squamous-cell carcinoma regardless of type VII collagen expression. J Invest Dermatol (2007) 1.57
A comparison of injection and non-injection methamphetamine-using HIV positive men who have sex with men. Drug Alcohol Depend (2004) 1.57